RTIX Related Analyst Ratings
-
Roth Capital Downgrades RTI Biologics (RTIX) to Neutral
-
Raymond James Upgrades RTI Biologics (RTIX) to Market Perform
-
JMP Securities Starts RTI Biologics (RTIX) at Market Outperform
-
Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX); Solid Q2; Shares Inexpensive
-
Roth Capital Upgrades RTI Biologics (RTIX) to Buy
-
Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX) Following Presentation at AAOS Conference
-
Canaccord Genuity Q4 Ortho Preview: Comments on ATEC, BMTI, EXAC, IART, RTIX, SYK, TSON & ZMH
-
Raymond James Downgraded Four Medical Instruments & Supplies Stocks
-
Raymond James Downgrades RTI Biologics (RTIX) to Underperform
-
Benchmark Raises Price Target on RTI Biologics (RTIX), Starting to Become a Growth Stroy
-
Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX); Beat and Raise in Difficult Market; Spine Outperformed
-
Benchmark Upgrades RTI Biologics (RTIX) to Buy, Strong Earnings and Less Risk
-
Craig-Hallum Upgrades RTI Biologics (RTIX) to Buy
-
Benchmark Downgrades RTI Biologics (RTIX) to Hold; Shares Reflect Recent Progress
-
Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX); Direct Distribution and New Products to Provide Consistency and Growth
-
Benchmark Cuts RTI Biologics (RTIX) to Hold
-
Canaccord Genuity on Life Sciences -- Biomedical Devices and Services: Takeaways from Global Growth Conference
-
RTI Biologics (RTIX) Shares Continuing Lower as Craig-Hallum Cuts to Accumulate
-
Benchmark Initiates Coverage on RTI Biologics Inc. (RTIX) with a Buy
-
Raymond James Downgrades RTI Biologics (RTIX) to Market Perform
-
Roth Upgrades RTI Biologics (RTIX) to Buy
-
Jesup & Lamont Initiates RTI Biologics (RTIX) with a Buy
-
Roth Capital Initiates Coverage on RTI Biologics (RTIX) with a Hold
-
Pacific Growth Initiates Coverage on RTI Biologics (RTIX) with a Buy
-
Banc of America Initiates Coverage on Regeneration Technologies (RTIX)
-
Susquehanna Initiates Coverage on Regeneration Technologies (RTIX)
-
CE Unterberg raises their price target on Regeneration Tech (RTIX) to $11
-
WR Hambrecht Starts Regeneration Technologies (RTIX) at Buy
-
LIFC Lower on Reports of Illegal Tissue - Analyst Comments
Back to RTIX Stock Lookup
